CPP32/apopain (Caspase-3), a protease of the Ced-3/ICE family, is a central mediator in the apoptosis induced by TNF or anti-Fas. In this study we demonstrate that wortmannin, an inhibitor of PI-3K, enhances the activation of CPP32 (Caspase-3) and DNA fragmentation in TNF-treated U937 cells and antiFas-treated Jurkat cells. Caspase-3-like activity, Ac-DEVD-MCA cleavage activity, is enhanced by wortmannin in the range of the concentration (1 ± 100 nM) specifically inhibiting PI-3K. LY294002, another PI-3K inhibitor, also enhances Caspase-3-like activity, but inhibitors for myosin light chain kinase and calmodulin dependent kinase do not have any effect on the Caspase-3-like activity. Wortmannin (1 ± 100 nM) enhances the processing of Caspase-3 (32K) into active form (17K) in TNF-or anti-Fas-treated cells, but not in untreated cells. These observations suggest that inhibition of PI-3K induces the activation of processing enzyme of Caspase-3 or increases the susceptibility of Caspase-3 to the processing enzyme. PI-3K seems to protect the cells from apoptosis by suppressing the activation of Caspase-3.
Introduction
Apoptosis is of fundamental importance to biological processes in embryogenesis, the immune system, and the nervous system (Ellis et al, 1991) . Considerable evidence suggests that Ced-3/ICE-cysteine proteases (Caspases) are components of the mammalian cell death pathway Miura et al, 1993) . CPP32/apopain (Caspase-3), which is most closely related to the CED-3 among Caspases (Fernandes-Alnemri et al, 1994) , is important in apoptosis induced by anti-Fas or TNF ; Poly ADP-ribose polymerase (PARP), an enzyme involved in DNA repair and genome surveillance and integrity, is one of a potential substrates for Caspase-3 during apoptosis . Inhibition of Caspase-3 activation attenuates apoptosis induced by anti-Fas or TNF . Caspase-3 (32K) is processed into active form (17K and 12K) during apoptosis induced by anti-Fas or TNF (Nicholson et al, 1995; Schlegel et al, 1996) .
Determination of the molecular mechanism for the activation of the proteases by the receptors has progressed recently. Fas and TNFR1 share a homologous region, appropriately designated the death domain, required to signal apoptosis (Itoh and Nagata, 1993; Tartaglia et al, 1993) . Both receptors interact with a related set of signaltransducing molecules containing the death domain, TNFR1-associated death domain (TRADD), Fas-associating protein with death domain (FADD)/MORT1 and receptor-interacting protein (RIP) (Cleveland and Ihle, 1995; Hsu et al, 1995; Chinnaiyan et al, 1995; Stanger et al, 1995; Boldin et al, 1995) . The dominant-negative version of FADD blocks TNF-and anti-Fas-mediated apoptosis, suggesting that FADD functions as the common signaling conduit for TNF-and anti-Fas-mediated cell death (Chinnaiyan et al, 1996b; Hsu et al, 1996) . FLICE/MACH/Mch-5 (Caspase-8), a novel cysteine protease of the Ced-3/ICE family containing a prodomain homologous to FADD, directly binds with the death effector domain of FADD (Muzio et al, 1996; Boldin et al, 1996; Fernandes-Alnemri et al, 1996) . Fas or TNFR1 utilizes the adaptor protein FADD to engage Caspase-8, the apical component of a proteolytic cascade made up of Caspases.
On the other hand, protein phosphorylation suppresses the apoptosis of various cells; activation of PKC maintains CTL cell viability in the absence of IL-2, and a tyrosine kinase-dependent signal prevents glucocorticoid-induced apoptosis (Walker et al, 1993) . Apoptosis of hematopoietic cells is suppressed by signaling through the IL-3 and GM-CSF receptors (Kinoshita et al, 1995) . Proteolytic cascade of Caspases is also involved in the apoptosis induced by inhibition of phosphorylation signals. For instance, staurosporine, an inhibitor for protein kinase C, induces apoptosis and activates Caspase-3 at high concentration (Bertrand et al, 1994; Chinnaiyan et al, 1996a) .
PI-3K, which is associated with tyrosine kinase receptor, is activated by various growth factors such as EGF, insulin, insulin-like growth factor, PDGF and NGF (Cantley et al, 1991; Baxter et al, 1995) . Wortmannin, a specific inhibitor of PI-3K (Arcaro and Wymann, 1993) , inhibits the ability of NGF to prevent apoptosis of PC12 cells induced by a withdrawal of serum (Yao and Cooper, 1995) . Recently, we showed that Caspase-3-like activity, cleavage of Ac-DEVD-MCA, is increased in DRG neurons by a withdrawal of serum (Mukasa et al, 1997a) . Moreover, wortmannin enhances Caspase-3-like activity during neuronal differentiation of P19 EC cells induced by retinoic acid (Mukasa et al, 1997b) . Thus PI-3K seems to play a role as negative regulator for the activation of Caspase-3-like protease in the apoptosis of neuronal cells. To clarify a biological role of PI-3K in the apoptosis, we examined the effect of wortmannin on the apoptosis induced by TNF and anti-Fas.
Here we demonstrate that inhibition of PI-3K enhances the activation of Caspase-3, cleavage of Caspase-3, during apoptosis induced by TNF or anti-Fas.
Results
Wortmannin does-dependently inhibit the PI-3K in U937 cells and Jurkat cells ( Figure 1A) The synthesis of phosphatidylinositol 3-phosphate (PI-3P), a product of PI-3K, was decreased by wortmannin at 1 nM and completely inhibited at more than 100 nM. Since wortmannin enhanced the cell death of TNF-treated U937 cells and anti-Fas treated Jurkat cells at 100 nM (unpublished observation), we examined the effect of wortmannin on the cleavage of PARP, a natural substrate for Caspase-3, in the TNF-treated U937 cells and anti-Fas-treated Jurkat cells. TNF induced the partial cleavage of PARP at 50 U/ml and anti-Fas did not induce the cleavage of PARP at 25 ng/ml. Wortmannin (100 nM) clearly enhanced the cleavage of PARP in both TNF (50 U/ ml)-treated U937 cells and anti-Fas (25 ng/ml)-treated Jurkat cells ( Figure 1B ). These results suggest that inhibition of PI-3K is closely associated with the activation of Caspase-3-like protease.
To examine the effects of wortmannin on the activation of Caspase-3-like protease and apoptosis induced by TNF or anti-Fas in more detail, Caspase-3-like activity and Caspase-1-like activity were measured by using a synthetic peptide of PARP (Ac-DEVD-MCA) and a pro IL-1b (Ac-YVAD-MCA) as substrates, respectively. Caspase-3-like activity was dose-and time-dependently increased by both TNF and anti-Fas (Figure 2A ). Caspase-3-like activity increased in 3 h and achieved a maximum level at more than 100 U/ml of TNF or 100 ng/ml of anti-Fas. Wortmannin enhanced Caspase-3-like activity induced by TNF (50 U/ml) or anti-Fas (25 ng/ml) in a different manner (Figure 2A ). Wortmannin time-dependently enhanced Caspase-3-like activity of anti-Fas-treated Jurkat cells, while it transiently increased Caspase-3-like activity of TNF-treated U937 cells in 3 h. Caspase-3-like activity enhanced by wortmannin was 2 ± 4-fold greater than the maximum level of Caspase-3-like activity induced by TNF (200 U/ml) or anti-Fas (200 ng/ml) alone ( Figure 2B ). However, wortmannin (100 nM) alone slightly increased Caspase-3-like activity in Jurkat cells in 12 h and transiently increased it in U937 cells in 7 h. Thus wortmannin and TNF or wortmannin and anti-Fas synergistically induced the Caspase-3-like activity. However, Caspase-1-like activity was not enhanced by wortmannin.
Wortmannin (1 ± 1000 nM), which specifically inhibits PI-3K ( Figure 1A ), dose-dependently enhanced Caspase-3-like activity in the TNF (50 U/ml)-treated U937 cells or antiFas (25 ng/ml)-treated Jurkat cells ( Figure 3A ). Corresponding to the increase of Caspase-3-like activity, wortmannin doses-dependently enhanced DNA fragmentation induced by TNF (50 U/ml) or anti-Fas (25 ng/ml) ( Figure 3B ). Even at 1 nM, wortmannin enhanced Caspase-3-like activity and DNA fragmentation. At 1000 nM, wortmannin alone slightly, but significantly, has an ability to induce Caspase-3-like activity and DNA fragmentation.
Since, however, wortmannin also inhibits myosin light chain kinase at more than 1000 nM (Nakanishi et al, 1992) , we examined whether inhibition of myosin light chain kinase or other kinases may enhance the Caspase-3-like activity in the Jurkat cells treated with anti-Fas. LY294002, another PI-3K inhibitor, also enhanced Caspase-3-like activity at the concentration (10 ± 50 mM) inhibiting PI-3K. ML-9 (myosin light chain kinase inhibitor) as well as KN-93 (calmodulin kinase inhibitor) had no effects on the Caspase-3-like activity of anti-Fas-treated Jurkat cells at 10 mM (Figure 4) . Similar results were obtained in the case of TNF-treated U937 cells except for the effect of KN-93 (unpublished observation).
Since Caspase-3 (32K) is processed into active form (17K) during apoptosis induced by anti-Fas (Nicholson et al, 1995; Schlegel et al, 1996) , we examined the processing of Caspase-3 molecules during apoptosis enhanced by wortmannin ( Figure 6 ). We prepared cleavesite directed antiserum against Caspase-3 (anti-p17). AntiCaspase-3 (anti-p32) reacted with a band with 32K (p32), but not an active fragment with 17K (p17), while anti-p17 reacted with p17, but not p32 ( Figure 5 ). These results show that anti-p17 specifically recognizes the cleavage site of Caspase-3 only after its cleavage.
The processing of p32 into p17, which was slightly detected in the TNF (50 U/ml)-treated U937 cells and antiFas (25 ng/ml)-treated Jurkat cells, was dose-dependently enhanced by wortmannin (1 ± 100 nM). However, the processing was not detected in the cells treated with wortmannin (1 ± 100 nM) alone ( Figure 6 ). Wortmannin induced the processing of Caspase-3 only at high concentration, more than 1000 nM (unpublished observation).
Discussion
PI-3K phosphorylates the D-3 position of the inositol ring of phosphatidylinositol and produces PI-3P, which is distinct from the major mono-phosphate form of phosphatidylinositol, phosphatidylinositol 4-phosphate (Carpenter and Canter, 1990) . Considerable evidence suggests that inhibition of PI-3K is involved in the apoptosis of neuronal cells induced by a withdrawal of serum or retinoic acid (Yao and Cooper, 1995; Mukasa et al, 1997b) . However, it has not been shown whether PI-3K regulates the apoptosis induced by TNF or anti-Fas.
We examined the effects of wortmannin on the PI-3K activity, Caspase-3-like activity, i.e., cleavage of PARP and Ac-DEVD-MCA, and DNA fragmentation in the TNFR1-or Fas-mediated apoptosis. Wortmannin enhances Caspase-3-like activity and DNA fragmentation in the 1 ± 1000 nM range of concentration, in which PI-3K activity is specifically Regulation of the activation of CPP32 by PI-3K E Fujita et al inhibited (Figures 1 and 3) . These results suggest that wortmannin enhances Caspase-3-like activity and the DNA fragmentation induced by TNF or anti-Fas by inhibiting PI-3K. Since, however, wortmannin also inhibits myosin light chain kinase and PI-4K at more than 1000 nM and 100 nM, respectively (Nakanishi et al, 1992; Okada et al, 1994) , we examined whether inhibition of myosin light chain kinase also enhances Caspase-3-like activity induced by anti-Fas. ML-9, a myosin light chain kinase inhibitor, had no effect on Caspase-3-like activity induced by anti-Fas (Figure 4 ), while LY294002, another PI-3K inhibitor, enhanced it. Thus PI-3K, but not myosin light chain kinase, must be involved in the negative regulation of the activation of Caspase-3-like protease. However, we do not exclude the possibility that PI-4K, which is inhibited by wortmannin at more than 100 nM (Okada et al, 1994) , is also involved in the inactivation of Caspase-3-like protease, because phosphatidylinositol-3,4-bisphosphate, a product of PI-3K and PI-4K, activates serine-threonine protein kinase Akt, which inhibits the apoptosis of neuronal cells induced by serum deprivation (Dudek et al, 1997; Franke et al, 1997) . Many Caspases such as Caspase-3, Mch-3 (Caspase-7) and Caspase-8, have the ability to cleave Ac-DEVD-MCA. To examine whether the enhancement of the cleavage of Ac-DEVD-MCA is due to the activation of Caspase-3 enhanced by wortmannin, we prepared the cleavage sitedirected antiserum against Caspase-3 (anti-p17) ( Figure 5A and B). It is possible to detect the activation of protease by the cleavage site-directed antiserum against target molecules (Saido et al, 1993) . Activation of calpain, which is induced by its autoprocessing, can also be detected by the antiserum against cleavage site of calpain (Kikuchi and Imajoh-Ohmi, 1995) . Caspase-3 is activated by processing of the inactive form ( 12K) during apoptosis induced by anti-Fas (Nicholson et al, 1995; Schlegel et al, 1996) . The anti-p17 specifically reacts with the pentapeptide of cleavage site of Caspase-3 only after its cleavage ( Figure 5A and B). Active fragment (p17) of Caspase-3 in TNF-or anti-Fas-treated cells was dosedependently increased by wortmannin (1 ± 100 nM) ( Figure  6A and B), clearly showing that wortmannin enhanced the processing of Caspase-3 induced by TNF or anti-Fas. The reactivity of anti-p17 was examined by immunoblot analysis. Anti-p32 was used for the detection of p32 of proCaspase-3. 1, 4, and 7, Histag-p32; 2, 5, and 8, GST-p17; 3, 6, and 9, GST-Shh-N. 1 ± 3, Histag-p32 (1 mg), GST-p17 (1 mg) and GST-Shh-N (2 mg) were stained with Coommasie brilliant blue; 4 ± 6, Histag-p32 (10 ng), GST-p17 (10 ng) and GST-Shh-N (20 ng) reacted with antip17; 7 ± 9, Histag-p32 (10 ng), GST-p17 (10 ng Jurkat cells were treated with wortmannin (1 ± 100 nM) in the presence or absence of anti-Fas (25 ng/ml) for 7 h. Upper panel and lower panel are immunoblot analysis using anti-p32 and anti-p17, respectively. Lane 1, untreated cells; lanes 2 and 6, 1 nM wortmannin; lanes 3 and 7, 10 nM wortmannin; lanes 4 and 8, 100 nM wortmannin; Left panel, lanes 1 ± 4 without TNF; lanes 5 ± 8, with TNF; Right panel, lanes 1 ± 4 without anti-Fas; lanes 5 ± 8 with anti-Fas induced apoptosis (Enari et al, 1996) . Caspase-1 has an ability to cleave Caspase-3 to its active form in vitro . However, PI-3K inhibitors enhanced the activation of Caspase-3 without any elevation of Caspase-1-like activity (Figure 2 ), suggesting that enhancement of the cleavage of Caspase-3 by wortmannin is independent on the activation of Caspase-1-like protease. On the other hand, Caspase-8, upstream of Caspase-3 in the Fas-or TNFR1-mediated death signal pathway, has an ability to process Caspase-3 into active form (Muzio et al, 1996) . Since the cleavage of Ac-DEVD-MCA was slightly, but significantly, induced by wortmannin alone (Figure 3A) , Caspases with Ac-DEVD-MCA cleavage activity such as Caspase-8 may be a processing enzyme activated by wortmannin. The other possible mechanism is that wortmannin increases the susceptibility of Caspase-3 to the processing enzyme. Since wortmannin alone did not induce the cleavage of Caspase-3 at 1 ± 100 nM, inhibition of PI-3K may not directly activate the processing enzyme. Recently it has been shown that Ced-4, upstream of Ced-3 and downstream of Ced-9, has a complex with not only Ced-9 and Ced-3 but also their mammalian homologues Bcl-2 and Caspase-3 or -8 (Chinnaiyan et al, 1997; Wu et al, 1997) . Bcl-2 and Bcl-x L suppress the activation of Caspase-3 and apoptosis induced by staurosporine (Chinnaiyan et al, 1996a; Armstrong et al, 1996) . Survival factor IL-3 phosphorylates BAD and causes the loss of its deathpromoting effects by inhibiting heterodimerization with Bclx L (Zha et al, 1996; Wang et al, 1996) . Thus PI-3K may block the susceptibility of Caspase-3 to the processing enzyme by regulating the phosphorylation of Bcl-2 family proteins and making a complex with Caspase-3, Bcl-2 and Ced-4.
Further study about the molecular mechanism of PI-3K regulating the activation of Caspase-3 remain to be studied.
Materials and Methods
Detection of cell death U937 cells and Jurkat cells were cultured in RPMI-1640 medium containing 10% FCS in the CO 2 incubator at 378C. Cells were incubated with wortmannin (100 nM) (Sigma, St. Louis, MO) in the presence or absence of TNF (Dainihonseiyaku, Osaka, Japan) or antiFas (MBL, Nagoya, Japan) for 5 h. Cell viability was determined by trypan blue exclusion. Values represent the average viability from three independent wells (+s.d.) and are normalized to the percentage of viable cells remaining in the untreated cultures. Two independent experiments showed similar results.
Isolation of fragmented DNA
U937 cells and Jurkat cells were respectively cultured with TNF and anti-Fas in the presence or absence of wortmannin at various concentrations (1 ± 1000 nM). Cells were harvested, washed once with PBS, and used for DNA isolation. DNA isolation was accomplished according to the method described by Pringent et al (1993) with some modification. Four hundred ml of lysis buffer (20 mM Tris-HCl, pH 7.4, 20 mM EDTA and 1% Triton X-100) was added to 2610 6 cells and suspended. Lysis was allowed to proceed on ice for 10 min and the mixture was centrifuged for 10 min at 15 000 r.p.m. The supernatant was digested with 50 mg/ml RNase A at 378C for 1 h. This was followed by a Proteinase K digestion at 50 mg/ml, at 378C for 1 h. After phenol-chloroform extraction, the DNA was precipitated by adding 2.5 vol. of 100% ethanol and CH 3 COONa (0.3 M at final concentration). DNA ladders could be visualized on 1.8% agarose gel.
Caspase-3-like and Caspase-1-like activity U937 cells and Jurkat cells were respectively incubated with TNF and anti-Fas at various concentrations in the presence of various kinase inhibitors such as wortmannin, LY294002 (Funakoshi, Tokyo), ML-9 and KN-93 (Seikagaku Co., Tokyo) for indicated periods. After incubation, cells were washed two times with PBS, and the cell pellets were lysed in PBS containing 0.2% Triton X-100 on ice for 10 min. After centrifugation at 10 0006g for 5 min, the cell extracts (50 mg protein) were incubated with 10 mM Ac-DEVD-MCA (Peptide Institute, Osaka), synthetic peptide of PARP, or Ac-YVAD-MCA (Peptide Institute, Osaka), synthetic peptide of pro IL-1b, in the incubation buffer (50 mM Tris-HCl pH 7.5, 1 mM DDT) for 20 min in order to measure Caspase-3-like or Caspase-1-like activities, respectively. The reactions were halted by the addition of 10% SDS. The fluorescence was measured at 380 nm for excitation and at 460 nm for emission.
Assay of PI-3K
PI-3K activity was assayed according to the procedure as described previously (Arcaro and Wymann, 1993) . U937 and Jurkat cells were incubated with wortmannin (Sigma, St. Louis, MO) at various concentration (1 ± 1000 nM) and were lysed with lysis buffer (20 mM Tris-HCl pH 7.5, 1 mM MgCl 2 , 1 mM CaCl 2 , 137 mM NaCl, 1 mM Na 3 VO 4 , 1% NP-40, 10% glycerol, 1 mM PMSF, 10 mg/ml leupeptin). After centrifugation at 13 0006g for 10 min, supernatant was incubated with anti-PI-3K (p85) (MBL, Nagoya) at 48C overnight. Immuno-complex was precipitated with a mixture of protein G and A, and suspended with 20 ml of 20 mM HEPES buffer (pH 7.4). The immuno-complex was incubated in the reaction buffer (20 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 10 mM ATP, 200 mg/ml phosphatidylinositol, 200 mg/ml phosphatidylserine, 1 mCi g-[ 32 P]ATP) at 258C for 10 min and then subjected to thin layer chromatography. Thin layer plate (Merck, Darmstadt, Germany) was developed with chloroform/ methanol/25% ammonia/H 2 O (86: 76: 10: 14). After development, thin layer plate was exposed to Fuji image analyzer.
Preparation of anti-p17
The antiserum against p17, active fragment (17K) of Caspase-3, was prepared according to a manual for the preparation of a cleavage sitedirected antibody against calpain (Saido et al, 1993; Kikuchi and Imajoh-Ohmi, 1995) . Anti-p17 was raised by injecting a synthetic pentapeptide of the cleavage site of human Caspase-3, GIETD, conjugated with KHL into rabbits. Anti-p17 antibody was purified by peptide affinity column chromatography. The cDNA fragments encoding the p32 (inactive form of Caspase-3) and p17 were amplified by PCR using the following primers, respectively: p32, 5'-GACATATG-GAGAACACTGAAAACTC-3' and 5'-GACATATGTTAGTGATAAAAA-TA G ; p 17 , 5' -A T GG GA A T AT C CC TG G AC A A C-3' a nd 5 '-CTAGTCTGTCTCAATGCCACA-3'. The PCR products were then cloned into the pCRII vector using the TA cloning kit (Invitrogen, San Diego, CA). Complement DNAs of p32 and p17 were subcloned inframe into the NdeI and EcoRI site of the bacterial expression vectors of pET15 (Novagen, Madison, WI) and pGEX-4T-2 (Pharmacia Biotech, Inc. Milwaukee, WI) for the preparation of Histag-p32 and GST-p17 fusion proteins, respectively. GST-p17 and Histag-p32 were purified by Glutathione and Nickel affinity column chromatography according to the manufacture's protocol, respectively. Purified fusion proteins were used for examining this specificity of anti-p17 by immunoblot analysis. GST-fusion protein of N-terminal region of rat sonic hedgehog (Shh-N) was used as a negative control (Urase et al, 1996) .
Immunoblot analysis
Cleavage of PARP and Caspase-3 was examined by immunoblot analysis. U937 cells and Jurkat cells were respectively incubated with TNF and anti-Fas in the presence or absence of PI-3K inhibitors for indicated period. For the extraction of Caspase-3, the cell pellets were lysed in PBS containing 0.2% Triton X-100 on ice for 10 min. For the extraction of PARP, the cell pellets were lysed with PBS containing 1% SDS and sonicated. After centrifugation at 10 0006g for 5 min, the cell extracts (40 mg protein) were subjected to the SDS acrylamide (12% or 15%) gel electrophoresis and immunoblot analysis using antip32 (Transduction Laboratories, Lexington, KY), anti-p17 and anti-PARP. The reactivities with anti-PARP, anti-p32 and anti-p17 on the filters were detected by peroxidase-conjugated goat anti-mouse and anti-rabbit immunoglobulin (ABC kit, Vector Lab., Burlingame, CA), respectively.
